Catherine M. Szyman - May 3, 2023 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role: CVP, Critical Care
Signature: Linda J. Park, Attorney-in-Fact
Stock symbol: EW
Transactions as of: May 3, 2023
Transactions value $: -$59,020
Form type: 4
Date filed: 5/4/2023, 09:49 PM
Previous filing: Feb 13, 2023
Next filing: May 9, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EW	Common Stock	Tax liability	-$28.7K	-327	-1.17%	$87.81	27.7K	May 3, 2023	Direct
transaction	EW	Common Stock	Tax liability	-$30.3K	-344	-1.24%	$88.10	27.4K	May 4, 2023	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This Form 4 includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.